Tagged with R

biotech Ignacio Pino, president of CDI Laboratories Inc., discusses how his novel technology platform Hu-Prot will help pharmaceutical companies and academia develop drugs more efficiently through development of advanced antibodies. How do you perceive the local life sciences industry of Puerto Rico? There is an increase in activity but still ample…

investment agency The Puerto Rico Industrial Development Company (PRIDCO) is a government agency underneath the Puerto Rican Department of Economic Development and Commerce designed to facilitate industrial investments in the country from abroad. Antonio Medina Comas, PRIDCO’s executive director, discusses the agency’s critical job in stimulating the economy while highlighting recent successes.…

Generics The general manager of Novagen Pharma reveals how they are the second largest supplier of ARVs within the private South African market, how there is much room for the generics market to grow given that it currently represents just one third of the total private market and how as the…

Thailand Servier Thailand’s general manager discusses the company’s competitive role in Thailand despite market challenges, the company’s ability to remain innovative and successful regardless of Thailand’s changing policies and Servier’s unique work culture.   Servier Thailand hopes to continue improving its service offerings in the local market by working closely with…

R&D The Thailand Institute of Scientific and Technological Research’s (TISTR) governor shares the institute’s role in facilitating R&D, the use of herbal medicine in Thailand and the future growth of R&D in Thailand. Currently, what are the main priorities for the Thailand Institute of Scientific and Technological Research (TISTR)? The organization…

Recordati Recordati’s South East regional VP, based in Istanbul, discusses Recordati Turkey’s key role as a manufacturing hub for Recordati, the importance of the Turkish market (fourth largest globally for the group) to the global organization, and current initiative to increase investment and develop a new manufacturing facility in the country.…

Chiesi Turkey is quickly becoming a regional hub for pharmaceutical industry for management, clinical trials and manufacturing, explains the general manager of Chiesi Turkey. How important is it for the government to clarify the incentives that have been discussed? The healthcare system in Turkey has undergone the largest transition in its…

Biocodex Biocodex’s new general manager gives an overview of the affiliates ‘new deal’ program, and how the company has adjusted its approach to better fit the contemporary Turkish environment. What attracted you to Biocodex Turkey? What are your impressions of the business so far? Biocodex made the right decision in starting…

Daiichi Sankyo The general manager of Daiichi Sankyo Turkey discusses his affiliate’s expansion into a regional hub, current strategies for growth in the Turkish market, and the keys behind his affiliates multiple ‘great place to work’ awards.  In 2012, you had made it a goal to develop the Turkish affiliate into a regional…

Korea The following table shows how Seoul has risen through the ranks of cities around the world to become the most competitive city for clinical trials of pharma products in 2012.

Korea Compared to the OECD average growth rate for healthcare expenditure, Korea’s growth in expenditure on medicines has remained fairly flat, dropping to zero growth in 2010 for example.

Korea Rapid overview of South Korea’s top ten pharma companies within the larger Asian context. The largest South Korean company, Yuhan, ranks 35th in Asia, with a turnover of U$ 862 million in 2013. For more data and stories from South Korea, download our latest 2015 free report here